Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on R Mandelic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Novel electrophilic substitution route for 3-hydroxymethyl-4-hydroxymandelic acid. Reduces steps, lowers cost, ensures high purity for asthma medication supply chains.
Novel resolution method using L-Tyrosine methyl ester achieves >99.5% ee. Cost-effective, scalable process for pharmaceutical intermediates.
Novel one-step synthesis patent CN103319335B offers high purity greater than 99 percent. Reduces equipment investment and enables green manufacturing for pharmaceutical intermediates.
Patent CN114315866B enables eco-friendly levamisole hydrochloride production via L-mandelic acid route eliminating chiral catalysts and reducing waste for enhanced supply chain resilience.